Promising potential of Lyprinol PCSO-524® to postpone or prevent the onset of neurodegenerative diseases like Alzheimer
March 2019
New clinical research simulating neuronal activity, conducted by the Division of Life Science, Hong Kong University of Science and Technology, shows that PCSO-524® (the active ingredient in Lyprinol®), protects cells under toxic inflammatory challenge. The researchers noted the promising potential of PCSO-524® to postpone or prevent the onset of neurodegenerative diseases like Alzheimer.
The first phase of the controlled study modelled human cell activity subjected to induced neuroinflammation. The study used controls to benchmark the results. Only the cells pre- treated with PCSO-524®, did not cascade into a lethal cell cycle re-entry, associated with Alzheimer’s disease. This was also tested in an animal model, with a similar preventative result.
One can conclude from the findings that PCSO-524® demonstrates a protection and prevention from cerebral related inflammatory cell destruction. However, the PCSO-524® did not demonstrate repair of damaged cells. Hence, the earlier Lyprinol® is included in one’s diet, the greater the protective benefits for age related mental health.